サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519736

経皮吸収パッチ市場レポート：タイプ、流通チャネル、用途、地域別、2024年～2032年

Transdermal Skin Patches Market Report by Type, Distribution Channel, Application, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 136 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
経皮吸収パッチ市場レポート：タイプ、流通チャネル、用途、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経皮吸収パッチの市場規模は2023年に79億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに112億米ドルに達し、2024年から2032年の間に3.9％の成長率（CAGR）を示すと予測しています。

経皮吸収パッチは、非侵襲的で使いやすいドラッグデリバリー方法で、一定量の治療薬をあらかじめ決められた時間にわたって血流に投与します。パッチは、バッキング、薬剤、メンブレン、接着剤、ライナー、化学増強剤や浸透剤、物理的補助剤、イオントフォレーシスのような微弱電流で構成されています。これらは、皮膚の特性やパッチのデザインに応じて、一定の拡散速度を提供します。現在では、化粧品、外用剤、経皮吸収型製剤として世界中で広く使用されています。

経皮吸収パッチ市場動向：

経皮吸収パッチは、心疾患やホルモン障害、片頭痛、パーキンソン病、アルツハイマー病、脳卒中、ヒト免疫不全ウイルス（HIV）、骨粗鬆症、レストレスレッグ症候群などの治療に有効です。したがって、これらの病気に苦しむ人口の割合が大幅に増加していることは、市場の成長を促す重要な要因の一つとなっています。さらに、これらのパッチは、医薬品を摂取するための伝統的な経口経路を避け、静脈内または非経口療法による不便さを軽減し、胃腸毒性、吐き気、嘔吐を防ぐのに役立ちます。さらに、経皮吸収パッチは投与が容易なため、慢性疼痛の長期治療や禁煙治療において、患者のコンプライアンスを向上させるために支持を集めています。これとは別に、手頃なコストでより良い治療法を求める需要の高まりと、異なる薬剤クラスの臨床試験件数の大幅な増加が、市場にプラスの影響を与えています。さらに、感圧接着剤と浸透促進剤のイントロダクションは、製品の拡散と薬物保持能力の向上につながり、市場プレーヤーに有利な機会を提供し、今後数年間で世界中の経皮吸収パッチのアプリケーションを拡大すると予測されています。

本レポートで扱う主な質問

  • 2023年における世界の経皮吸収パッチ市場の市場規模は？
  • 2024-2032年における世界の経皮吸収パッチ市場の予想成長率は？
  • 世界の経皮吸収パッチ市場を牽引する主な要因は？
  • 世界の経皮吸収パッチ市場に対するCOVID-19の影響は？
  • 世界の経皮吸収パッチ市場のタイプ別内訳は？
  • 世界の経皮吸収パッチ市場の主要地域は？
  • 世界の経皮吸収パッチ市場の主要プレーヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の経皮吸収パッチ市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 単層薬剤含有接着剤
    • 市場動向
    • 市場予測
  • 多層薬剤内接着剤
    • 市場動向
    • 市場予測
  • マトリックス
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンラインストア
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 痛みの緩和
    • 市場動向
    • 市場予測
  • 喫煙の減少と禁煙の支援
    • 市場動向
    • 市場予測
  • 過活動膀胱
    • 市場動向
    • 市場予測
  • ホルモン療法
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • AdhexPharma
    • LTS Lohmann Therapie-Systeme AG
    • Luye Pharma Group
    • Medherant Limited
    • Nitto Denko Corporation
    • Noven Pharmaceuticals Inc.（Hisamitsu Pharmaceutical Co. Inc.）
    • Prosolus Inc.
    • Samyang Holdings Corporation
    • Tapemark
    • Teikoku Pharma USA Inc.（Teikoku Seiyaku Co. Ltd）
    • tesa SE（Beiersdorf AG）
    • Teva Pharmaceutical Industries Ltd
図表

List of Figures

  • Figure 1: Global: Transdermal Skin Patches Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Skin Patches Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transdermal Skin Patches Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transdermal Skin Patches Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Transdermal Skin Patches Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Transdermal Skin Patches Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Transdermal Skin Patches Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Transdermal Skin Patches (Matrix) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Transdermal Skin Patches (Matrix) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Transdermal Skin Patches (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Transdermal Skin Patches (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Transdermal Skin Patches (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Transdermal Skin Patches (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Transdermal Skin Patches (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Transdermal Skin Patches (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Transdermal Skin Patches (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Transdermal Skin Patches (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Transdermal Skin Patches (Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Transdermal Skin Patches (Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Transdermal Skin Patches (Overactive Bladder) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Transdermal Skin Patches (Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Transdermal Skin Patches (Hormonal Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Transdermal Skin Patches (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Transdermal Skin Patches (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Transdermal Skin Patches (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Transdermal Skin Patches Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Transdermal Skin Patches Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Transdermal Skin Patches Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Transdermal Skin Patches Industry: SWOT Analysis
  • Figure 82: Global: Transdermal Skin Patches Industry: Value Chain Analysis
  • Figure 83: Global: Transdermal Skin Patches Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Skin Patches Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transdermal Skin Patches Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Transdermal Skin Patches Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Transdermal Skin Patches Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Transdermal Skin Patches Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Transdermal Skin Patches Market: Competitive Structure
  • Table 7: Global: Transdermal Skin Patches Market: Key Players
目次
Product Code: SR112024A5142

The global transdermal skin patches market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transdermal skin patches market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, distribution channel and application.

Breakup by Type:

Single-layer Drug-in-Adhesive

Multi-layer Drug-in-Adhesive

Matrix

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Breakup by Application:

Pain Relief

Smoking Reduction and Cessation Aid

Overactive Bladder

Hormonal Therapy

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global transdermal skin patches market in 2023?
  • 2. What is the expected growth rate of the global transdermal skin patches market during 2024-2032?
  • 3. What are the key factors driving the global transdermal skin patches market?
  • 4. What has been the impact of COVID-19 on the global transdermal skin patches market?
  • 5. What is the breakup of the global transdermal skin patches market based on the type?
  • 6. What is the breakup of the global transdermal skin patches market based on the application?
  • 7. What are the key regions in the global transdermal skin patches market?
  • 8. Who are the key players/companies in the global transdermal skin patches market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Skin Patches Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single-layer Drug-in-Adhesive
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Multi-layer Drug-in-Adhesive
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Smoking Reduction and Cessation Aid
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Overactive Bladder
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hormonal Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AdhexPharma
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 LTS Lohmann Therapie-Systeme AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Luye Pharma Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Medherant Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Nitto Denko Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Prosolus Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Samyang Holdings Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tapemark
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 tesa SE (Beiersdorf AG)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Teva Pharmaceutical Industries Ltd
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis